MD HB1421 | 2024 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on February 9 2024 - 25% progression
Action: 2024-02-09 - Hearing 3/07 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prohibiting a person from offering for sale in the State a gene structure- or function-modifying product unless the product is labeled in a prominent and conspicuous manner with the words "Gene structure- or function-modifying product" and all potential risks, side effects, adverse effects, and other reasonably possible effects that the product may have; and establishing penalties for a violation of the Act.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling

Sponsors


History

DateChamberAction
2024-02-09HouseHearing 3/07 at 1:00 p.m.
2024-02-09HouseFirst Reading Health and Government Operations

Same As/Similar To

SB911 (Crossfiled) 2024-02-09 - Hearing 3/07 at 1:00 p.m.

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Health - General21-3A101(n/a)See Bill Text
Health - General21-3A102(n/a)See Bill Text
Health - General21-3A103(n/a)See Bill Text
Health - General21-3A104(n/a)See Bill Text

Maryland State Sources


Bill Comments

feedback